The DOI matches its Crossref record; 320 of the 320 references it cites were found in a registry or an index.
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Open accessAbstract
The transforming growth factor-beta (TGF β) superfamily encompasses widespread and evolutionarily conserved polypeptide growth factors that regulate and orchestrate growth and differentiation in all cell types and tissues. While they regulate asymmetric cell division and cell fate determination during early development and embryogenesis, TGF β family members play a major regulatory role in hormonal and immune responses, cell growth, cell death and cell immortalization, bone formation, tissue remodeling and repair, and erythropoiesis throughout adult life. The biological and physiological functions of TGF β, the founding member of this family, and its receptors are of central importance to human diseases, particularly cancer. By regulating cell growth, death, and immortalization, TGF β signaling pathways exert tumor suppressor effects in normal cells and early carcinomas. Thus, it is not surprising that a high number of human tumors arise due to mutations or deletions in the genes coding for the various TGF β signaling components. As tumors develop and progress, these protective and cytostatic effects of TGF β are often lost. TGF β signaling then switches to promote cancer progression, invasion, and tumor metastasis. The molecular mechanisms underlying this dual role of TGF β in human cancer will be discussed in depth in this paper, and it will highlight the challenge and importance of developing novel therapeutic strategies specifically aimed at blocking the prometastatic arm of the TGF β signaling pathway without affecting its tumor suppressive effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–320 of 320
Sandhu, C., Garbe, J., Bhattacharya, N., Daksis, J., Pan, C.-H., Yaswen, P., Koh, J., Slingerland, J. M., & Stampfer, M. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2458 · Cited by 194
Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis
Yamamura, Y., Hua, X., Bergelson, S., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006023200 · Cited by 188
Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
Kim, S.-J., Im, Y.-H., Markowitz, S. D., & Bang, Y.-J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00039-8 · Cited by 188
Chen, R.-H., Su, Y.-H., Chuang, R. L., & Chang, T.-Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202111 · Cited by 186
Targeted Mutagenesis of Smad1 Reveals an Essential Role in Chorioallantoic Fusion
Lechleider, R. J., Ryan, J. L., Garrett, L., Eng, C., Deng, C.-X., Wynshaw-Boris, A., & Roberts, A. B. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0469 · Cited by 185
Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J., & Balmain, A. (1998) · PubMed · Cited by 185
Gotzmann, J., Huber, H., Thallinger, C., Wolschek, M., Jansen, B., Schulte-Hermann, R., Beug, H., & Mikulits, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1189 · Cited by 185
Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B., & Sporn, M. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9944 · Cited by 179
Transforming growth factor β 3 induces cell death during the first stage of mammary gland involution
Nguyen, A. V., & Pollard, J. W. (2000) · Development · doi:10.1242/dev.127.14.3107 · Cited by 179
The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex
Boominathan, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010615 · Cited by 178
Tian, F., Byfield, S. D., Parks, W. T., Yoo, S. S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., & Roberts, A. B. (2003) · PubMed · Cited by 177
Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat
Benigni, A., Zoja, C., Corna, D., Zatelli, C., Conti, S., Campana, M., Gagliardini, E., Rottoli, D., Zanchi, C., Abbate, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000074238.61967.b7 · Cited by 176
TGF-β and the Smad signal transduction pathway
Mehra, A., & Wrana, J. L. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-161 · Cited by 175
miR-200b mediates post-transcriptional repression of ZFHX1B
Christoffersen, N. R., Silahtaroglu, A., Ørom, U. A., Kauppinen, S., & Lund, A. H. (2007) · RNA · doi:10.1261/rna.586807 · Cited by 175
Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP
Valderrama-Carvajal, H., Cocolakis, E., Lacerte, A., Lee, E.-H., Krystal, G., Ali, S., & Lebrun, J.-J. (2002) · Nature Cell Biology · doi:10.1038/ncb885 · Cited by 169
Self-citationmiR-182 as a Prognostic Marker for Glioma Progression and Patient Survival
Jiang, L., Mao, P., Song, L., Wu, J., Huang, J., Lin, C., Yuan, J., Qu, L., Cheng, S.-Y., & Li, J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090812 · Cited by 167
Lebrun, J. J., & Vale, W. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1682 · Cited by 167
Self-citationXu, L., Chen, Y.-G., & Massagué, J. (2000) · Nature Cell Biology · doi:10.1038/35019649 · Cited by 166
Wicks, S. J., Lui, S., Abdel-Wahab, N., Mason, R. M., & Chantry, A. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.21.8103-8111.2000 · Cited by 166
Yanagisawa, K., Osada, H., Masuda, A., Kondo, M., Saito, T., Yatabe, Y., Takagi, K., Takahashi, T., & Takahashi, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202052 · Cited by 165
Lebrun, J.-J., Ali, S., Ullrich, A., & Kelly, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10664 · Cited by 165
Self-citationLoss of Smad3 in Acute T-Cell Lymphoblastic Leukemia
Wolfraim, L. A., Fernandez, T. M., Mamura, M., Fuller, W. L., Kumar, R., Cole, D. E., Byfield, S., Felici, A., Flanders, K. C., Walz, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031197 · Cited by 163
Atfi, A., Buisine, M., Mazars, A., & Gespach, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24731 · Cited by 162
TGF-β singaling and cancer: structural and functional consequences of mutations in Smads
Hata, A., Massagué, J., & Shi, Y. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01247-7 · Cited by 161
Dumont, N., Bakin, A. V., & Arteaga, C. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204623200 · Cited by 159
Transforming Growth Factor-β1 Triggers Hepatocellular Carcinoma Invasiveness via α3β1 Integrin
Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Colucci, S. C., Schiraldi, O., & Antonaci, S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64170-3 · Cited by 158
Dusanter‐Fourt, I., Muller, O., Ziemiecki, A., Mayeux, P., Drucker, B. J., Djiane, J., Wilks, A. F., Harpur, A. G., Fischer, S., & Gisselbrecht, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06548.x · Cited by 157
Yan, Z., Winawer, S. J., & Friedman, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36823-0 · Cited by 153
The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization.
Chacko, B. M., Qin, B. Y., Correia, J. J., Lam, S. S., de Caestecker, M. P., & Lin, K. F. (2001) · Nature Structural Biology · doi:10.1038/84995 · Cited by 151
Karumanchi, S. A., Knebelmann, B., Grüning, W., Dhanabal, M., Walz, G., Stillman, I. E., & Sukhatme, V. P. (1999) · PubMed · Cited by 147
PTP1D is a positive regulator of the prolactin signal leading to beta‐casein promoter activation.
Ali, S., Chen, Z., Lebrun, J. J., Vogel, W. F., Kharitonenkov, A., Kelly, P. A., & Ullrich, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00341.x · Cited by 140
Self-citationSubramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakravarty, S., Dugar, S., & Reiss, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0018 · Cited by 138
Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
Zhang, B., Halder, S. K., Zhang, S., & Datta, P. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.035 · Cited by 134
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization
Rui, H., Lebrun, J. J., Kirken, R. A., Kelly, P. A., & Farrar, W. L. (1994) · Endocrinology · doi:10.1210/en.135.4.1299 · Cited by 131
Self-citationTransforming Growth Factor-β Receptors Interact with AP2 by Direct Binding to β2 Subunit
Yao, D., Ehrlich, M., Henis, Y. I., & Leof, E. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-07-0104 · Cited by 129
Cocolakis, E., Lemay, S., Ali, S., & Lebrun, J. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010768200 · Cited by 129
Self-citationCasey, T. M., Eneman, J., Crocker, A., White, J., Tessitore, J., Stanley, M., Harlow, S., Bunn, J. Y., Weaver, D., Muss, H., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9684-7 · Cited by 127
Molecular targets in pituitary tumours
Heaney, A. P., & Melmed, S. K. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1320 · Cited by 125
Coronary Vessel Development Is Dependent on the Type III Transforming Growth Factor β Receptor
Compton, L. A., Potash, D. A., Brown, C. B., & Barnett, J. V. (2007) · Circulation Research · doi:10.1161/circresaha.107.152082 · Cited by 125
Distinct Oligomeric States of SMAD Proteins in the Transforming Growth Factor-β Pathway
Jayaraman, L., & Massagué, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005799200 · Cited by 119
Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells
Azuma, H., Ehata, S., Miyazaki, H., Watabe, T., Maruyama, O., Imamura, T., Sakamoto, T., Kiyama, S., Kiyama, Y., Ubai, T., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji399 · Cited by 115
Lebrun, J. J., Ali, S., Goffin, V., Ullrich, A., & Kelly, P. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.4031 · Cited by 114
Self-citationDefining the Role of Prolactin as an Invasion Suppressor Hormone in Breast Cancer Cells
Nouhi, Z., Chughtai, N., Hartley, S., Cocolakis, E., Lebrun, J. J., & Ali, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2292 · Cited by 111
Self-citationBurrow, A. A., Williams, L. E., Pierce, L., & Wang, Y. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-59 · Cited by 110
Goumans, M., Zwijsen, A., van Rooijen, M. A., Huylebroeck, D., Roelen, B. A. J., & Mummery, C. L. (1999) · Development · doi:10.1242/dev.126.16.3473 · Cited by 110
Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1
Guo, S. S., & Sawicki, M. P. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0717 · Cited by 109
Ohgushi, M., Kuroki, S., Fukamachi, H., O’Reilly, L. A., Kuida, K., Strasser, A., & Yonehara, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10017-10028.2005 · Cited by 109
Dual Role of SnoN in Mammalian Tumorigenesis
Zhu, Q., Krakowski, A., Dunham, E. E., Wang, L., Bandyopadhyay, A. M., Berdeaux, R., Martin, G. S., Sun, L., & Luo, K. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01394-06 · Cited by 108
Hermida, N., López, B., González, A., Dotor, J., Lasarte, J. J., Sarobe, P., Borrás‐Cuesta, F., & Dı́ez, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn315 · Cited by 107
Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor Signaling
Lebrun, J. J., Takabe, K., Chen, Y., & Vale, W. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0218 · Cited by 103
Self-citationTsapara, A., Luthert, P. J., Greenwood, J., Hill, C. S., Matter, K., & Balda, M. S. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-07-0567 · Cited by 103
Chipuk, J. E., Bhat, M. B., Hsing, A. Y., Ma, J., & Danielpour, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100913200 · Cited by 100
Peng, S.-B., Yan, L., Xia, X., Watkins, S. A., Brooks, H. B., Beight, D. W., Herron, D. K., Jones, M. L., Lampe, J. W., McMillen, W. T., et al. (2005) · Biochemistry · doi:10.1021/bi048851x · Cited by 100
Saltzman, A. G., Munro, R., Searfoss, G. H., Franks, C. F., Jaye, M., & Ivashchenko, Y. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4096 · Cited by 98
Wang, J., Yang, L., Yang, J., Kuropatwinski, K. K., Wang, W., Liu, X.-Q., Hauser, J., & Brattain, M. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5348 · Cited by 98
The G protein‐coupled receptor kinase‐2 is a TGFβ‐inducible antagonist of TGFβ signal transduction
Ho, J., Cocolakis, E., Dumas, V. M., Posner, B. I., Laporte, S. A., & Lebrun, J. J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600794 · Cited by 98
Self-citationWildey, G. M., Patil, S. D., & Howe, P. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211958200 · Cited by 98
Inhibiting TGF-β signaling restores immune surveillance in the SMA-560 glioma model
Tran, T.-T., Uhl, M., Jing, Y., et al. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-010 · Cited by 96
Fukai, Y., Fukuchi, M., Masuda, N., Osawa, H., Kato, H., Nakajima, T., & Kuwano, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10929 · Cited by 95
Rowland‐Goldsmith, M., Maruyama, H., Kusama, T., Ralli, S., & Korc, M. (2001) · PubMed · Cited by 93
Nagata, H., Hatano, E., Tada, M., Murata, M., Kitamura, K., Asechi, H., Narita, M., Yanagida, A., Tamaki, N., Yagi, S., et al. (2009) · Hepatology · doi:10.1002/hep.22860 · Cited by 93
Walker, R. A., Dearing, S. J., & Gallacher, B. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.228 · Cited by 92
Tajima, Y., Goto, K., Yoshida, M., Shinomiya, K., Sekimoto, T., Yoneda, Y., Miyazono, K., & Imamura, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212663200 · Cited by 92
Involvement of CTGF, a Hypertrophic Chondrocyte-Specific Gene Product, in Tumor Angiogenesis
Shimo, T., Nakanishi, T., Nishida, T., Asano, M., Sasaki, A., Kanyama, M., Kuboki, T., Matsumura, T., & Takigawa, M. (2001) · Oncology · doi:10.1159/000055339 · Cited by 92
Hannigan, A., Smith, P., Kalna, G., Lo Nigro, C., Orange, C., O’Brien, D. I., Shah, R., Syed, N., Spender, L. C., Herrera, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36125 · Cited by 92
Rowland‐Goldsmith, M., Maruyama, H., Matsuda, K., Idezawa, T., Ralli, M., Ralli, S., & Korc, M. (2002) · PubMed · Cited by 92
Hill, C., Flyvbjerg, A., Rasch, R., Bak, M., & Logan, A. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700647 · Cited by 90
Role of miRNA in carcinogenesis and biomarker selection: a methodological view
Ahmed, F. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.5.569 · Cited by 90
TGF-β Promotes the Establishment of Renal Cell Carcinoma Bone Metastasis
Kominsky, S. L., Doucet, M., Brady, K., & WEBER, K. L. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061005 · Cited by 89
Robinson, S. D., Roberts, A. B., & Daniel, C. W. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.120.1.245 · Cited by 88
Hagedorn, H. G., Bachmeier, B. E., & Nerlich, A. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.669 · Cited by 87
In or out? The dynamics of Smad nucleocytoplasmic shuttling
Reguly, T., & Wrana, J. L. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00075-8 · Cited by 85
Chughtai, N., Schimchowitsch, S., Lebrun, J. J., & Ali, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200156200 · Cited by 84
Self-citationTGF-β inhibitors for the treatment of cancer
Lahn, M. M. F., Kloeker, S., & Berry, B. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.629 · Cited by 84
Yang, H., Kyo, S., Takatura, M., & Sun, L. (2001) · PubMed · Cited by 84
Neel, J.-C., & Lebrun, J. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.03.013 · Cited by 83
Self-citationTian, F., Byfield, S. D., Parks, W. T., Stuelten, C. H., Nemani, D., Zhang, Y. E., & Roberts, A. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0030 · Cited by 82
Fils-Aimé, N., Dai, M., Guo, J., El-Mousawi, M., Kahramangil, B., Neel, J.-C., & Lebrun, J. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.430934 · Cited by 80
Self-citationGo, C., Li, P., & Wang, X. (1999) · PubMed · Cited by 79
Chaouchi, N., Arvanitakis, L., Auffredou, M., Blanchard, D. A., Vázquez, A., & Sharma, S. (1995) · PubMed · Cited by 79
Morris, J. C., Shapiro, G. I., Tan, A. R., Lawrence, D. P., Olencki, T. E., Dezube, B. J., Hsu, F. J., Reiss, M., & Berzofsky, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.9028 · Cited by 78
Dong, Y., Tang, L., Letterio, J. J., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.311 · Cited by 77
Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression
Yang, J., Song, K. W., Krebs, T. L., Jackson, M. W., & Danielpour, D. (2008) · Oncogene · doi:10.1038/onc.2008.165 · Cited by 76
Bertrán, E., Caja, L., Navarro, E., Sancho, P., Mainez, J., Murillo, M. M., Vinyals, A., Fabra, À., & Fabregat, I. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.06.006 · Cited by 75
Role of the α3β1 and α6β4 integrins in tumor invasion
Giannelli, G., Astigiano, S., Antonaci, S., Morini, M., Barbieri, O., Noonan, D. M., & Albini, A. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015579204607 · Cited by 74
Distinct regulation of gene expression in human endothelial cells by TGF-β and its receptors
Wu, X., Ma, J., Han, J. J., Wang, N., & Chen, Y. (2006) · Microvascular Research · doi:10.1016/j.mvr.2005.11.004 · Cited by 71
Transforming growth factor-β inhibits telomerase through SMAD3 and E2F transcription factors
Lacerte, A., Korah, J., Roy, M., Yang, X., Lemay, S., & Lebrun, J. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.012 · Cited by 68
Self-citationKomesli, S., Vivien, D., & Dutartre, P. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540505.x · Cited by 64
Dai, M., Al-Odaini, A. A., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3322 · Cited by 62
Self-citationLoss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer
Maliekal, T. T., Antony, M. L., Nair, S. A., Paulmurugan, R., & Karunagaran, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206806 · Cited by 61
Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines
Cerutti, J. M., Ebina, K. N., Matsuo, S. E., Martins, L., Maciel, R. M. B., & Kimura, E. T. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345213 · Cited by 61
Activin Inhibits Pituitary Prolactin Expression and Cell Growth through Smads, Pit-1 and Menin
Lacerte, A., Lee, E.-H., Reynaud, R., Canaff, L., de Guise, C., Devost, D., Ali, S., Hendy, G. N., & Lebrun, J. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0470 · Cited by 61
Self-citationCocolakis, E., Dai, M., Drevet, L., Ho, J., Haines, E., Ali, S., & Lebrun, J. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707492200 · Cited by 59
Self-citationOverexpression of the TGF-β antagonist Smad7 in endometrial cancer
Dowdy, S. C., Mariani, A., Reinholz, M. M., Keeney, G. L., Spelsberg, T. C., Podratz, K. C., & Janknecht, R. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.006 · Cited by 59
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions
Grütter, C., Wilkinson, T. C. I., Turner, R., Podichetty, S., Finch, D. K., McCourt, M., Loning, S., Jermutus, L., & Grütter, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807200106 · Cited by 56
Strategies for TGF-β modulation: a review of recent patents
Bonafoux, D., & Lee, W. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903397400 · Cited by 55
Yakymovych, I., Engström, U., Grimsby, S., Heldin, C., & Souchelnytskyi, S. (2002) · Biochemistry · doi:10.1021/bi025936u · Cited by 51
Regulation of telomerase during human placental differentiation: a role for TGFβ1
Rama, S., Suresh, Y., & Rao, A. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00550-0 · Cited by 49
Ho, J., de Guise, C., Kim, C., Lemay, S., Wang, X., & Lebrun, J. J. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.11.002 · Cited by 48
Self-citationCasein Kinase Iϵ Plays a Functional Role in the Transforming Growth Factor-β Signaling Pathway
Waddell, D. S., Liberati, N. T., Guo, X., Frederick, J. P., & Wang, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400880200 · Cited by 47
de Guise, C., Lacerte, A., Rafiei, S., Reynaud, R., Roy, M., Brue, T. C., & Lebrun, J. J. (2006) · Endocrinology · doi:10.1210/en.2006-0444 · Cited by 46
Self-citationTransforming growth factor-β increases interleukin-6 transcripts in osteoblasts
Franchimont, N., Rydziel, S., & CANALIS, E. M. (2000) · Bone · doi:10.1016/s8756-3282(99)00275-6 · Cited by 45
Mieth, M., Boehmer, F., Ball, R., Groner, B., & Grosse, R. (1990) · Growth Factors · doi:10.3109/08977199009011005 · Cited by 45
A fully human antibody neutralising biologically active human TGFβ2 for use in therapy
Thompson, J. E., Vaughan, T. J., Williams, A. J., Wilton, J., Johnson, K. S., Bacon, L., Green, J. A., Field, R. P., Ruddock, S., MARTINS, M. S., et al. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00060-5 · Cited by 44
Daniel, C. W., Robinson, S. D., & Silberstein, G. B. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1371-1_7 · Cited by 43
Kanamaru, C. (2002) · Hepatology Research · doi:10.1016/s1386-6346(01)00175-9 · Cited by 43
Ramont, L., Brassart‐Pasco, S., Hornebeck, W., Maquart, F., & Monboisse, J. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00336-7 · Cited by 41
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-β signaling
Ge, R., Rajeev, V., Subramanian, G., Reiss, K. A., Liu, D., Higgins, L. S., Joly, A. H., Dugar, S., Chakravarty, J., Henson, M., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.011 · Cited by 40
Schlingensiepen, K.-H., Bischof, A., Egger, T., Hafner, M. R., Herrmuth, H., Jachimczak, P., Kielmanowicz, M., Niewel, M., Závadová, E., & Stauder, G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.3132 · Cited by 39
Calvo, E., Baselga, J. M., Glatt, S., Cleverly, A., Lahn, M., Arteaga, C. L., Rothenberg, M. L., & Carducci, M. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.14554 · Cited by 38
Péron, P., Rahmani, M., Zagar, Y., Durand‐Schneider, A., Lardeux, B. R., & Bernuau, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005919200 · Cited by 35
Javor, J., Ferenčík, S., Bucová, M., Stuchlíková, M., Martinka, E., Barák, Ľ., Strbová, L., Grosse‐Wilde, H., & Buc, M. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0092-z · Cited by 33
Receptor Serine Kinases and Signaling by Activins and Inhibins
Lebrun, J. J., Chen, Y., & Vale, W. (1997) · Springer eBooks · doi:10.1007/978-1-4612-1874-6_1 · Cited by 29
Self-citationGuo, J., Chen, H., Ho, J., Mancini, J., Sontag, T., Laporte, S. A., Richard, D. E., & Lebrun, J. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.037 · Cited by 29
Self-citationActivin, TGF-β and Menin in Pituitary Tumorigenesis
Lebrun, J. J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1664-8_7 · Cited by 27
Self-citationSudlow, A. W., WILDE, C. J., & Burgoyne, R. D. (1994) · Biochemical Journal · doi:10.1042/bj3040333 · Cited by 24
Engulfment Protein GULP Is Regulator of Transforming Growth Factor-β Response in Ovarian Cells
Ma, C.-I. J., Martin, C., Ma, Z., Hafiane, A., Dai, M., Lebrun, J. J., & Kiss, R. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.314997 · Cited by 21
Self-citationKirch, H.-C., Pützer, B. M., Brockmann, D., Esche, H., & Kloke, O. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00736.x · Cited by 13
Novel dominant negative Smad antagonists to TGFβ signaling
Ho, J., Chen, H., & Lebrun, J. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.02.001 · Cited by 11
Self-citationEmerging drugs in metastatic breast cancer: an update
Arslan, Ç., Altundağ, K., & Dızdar, Ö. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.640672 · Cited by 9
Cited by
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Lan, Y., Zhang, D., Xu, C., Hance, K. W., Marelli, B., Qi, J., Yu, H., Qin, G., Sircar, A., Hernández, V. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5488 · Cited by 494
Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis
Shu, D. Y., & Lovicu, F. J. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.08.001 · Cited by 387
PD-1/PD-L1 and immunotherapy for pancreatic cancer
Feng, M., Xiong, G., Cao, Z., Yang, G., Zheng, S., Song, X., You, L., Zheng, L., Zhang, T., & Zhao, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.006 · Cited by 318
EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration
Shu, D. Y., Butcher, E., & Saint-Geniez, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124271 · Cited by 292
Metadata
- Authors
- Neel, J.-C., Humbert, L., & Lebrun, J.-J.
- Venue
- ISRN Molecular Biology
- Publisher
- Wiley
- Published
- 2012-12-24
- Volume
- 2012
- Pages
- 1-28
- ISSN
- 2090-7907 (ISSN-L)
- OpenAlex
- W1966857167
- Cited by
- 345
- References
- 320
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.